Deep vein thrombosis (DVT) in the leg is a serious medical condition that can become life-threatening if a clot breaks free and travels to the lungs. Within one month of diagnosis, DVT carries a mortality rate of roughly 6%, and that figure doubles to 12% if a pulmonary embolism (PE) occurs. With prompt treatment, though, the vast majority of people survive and recover well. The real question isn’t just whether DVT is dangerous in the moment, but what it means for your health in the weeks, months, and years that follow.
The Biggest Immediate Risk: Pulmonary Embolism
The most dangerous complication of leg DVT is a pulmonary embolism, which happens when part of the clot dislodges and lodges in the blood vessels of the lungs. About 40% of people with a proximal DVT (one that forms in the thigh or pelvis rather than below the knee) already have an associated pulmonary embolism detectable on a lung scan at the time of diagnosis, even if they don’t yet feel symptoms of it. And looking at it from the other direction, roughly 70% of people who show up with a pulmonary embolism have a DVT in their legs.
PE can range from mild to fatal. Warning signs include sudden shortness of breath, chest pain that worsens when you breathe deeply or cough, a rapid pulse, feeling lightheaded or faint, and coughing up blood. Any combination of these symptoms alongside a known or suspected DVT is a medical emergency.
Location of the Clot Changes the Risk
Not all leg DVTs carry the same level of danger. Clots that form in the thigh or pelvic veins (proximal DVT) are significantly more serious than those limited to the calf (distal DVT). In one large registry study, the 90-day mortality rate for patients with proximal DVT was 7.9%, compared to 2.5% for distal DVT and 1.4% for patients without any DVT at all.
Distal clots are still worth treating and monitoring because they can extend upward into the proximal veins over time. But a clot that’s already in the thigh or higher demands more urgent attention and closer follow-up. If you’ve been told you have a DVT, ask your doctor specifically where the clot is located, because the answer meaningfully affects your outlook.
Survival Rates With Treatment
When DVT is diagnosed and treated with blood thinners, the prognosis is considerably better than the raw mortality numbers might suggest. In a large cohort study that excluded the first 30 days after diagnosis, the one-year mortality rate was 4% overall. For patients without an underlying cancer, it dropped to just 0.7%. Cancer was the leading cause of death in both proximal and distal DVT groups, meaning much of the mortality associated with DVT reflects the serious illnesses that caused the clot in the first place rather than the clot itself.
Pulmonary embolism is more lethal, with 10% to 20% of PE patients dying within three months. This is why preventing a DVT from becoming a PE through timely treatment is so critical.
What Treatment Looks Like
The standard treatment for DVT is anticoagulant therapy, commonly called blood thinners. These medications don’t dissolve the existing clot but prevent it from growing and reduce the risk of new clots forming while your body gradually breaks down the original one.
Current guidelines from the American Society of Hematology recommend 3 to 6 months of anticoagulation as the initial course, regardless of whether the DVT was triggered by a specific event (like surgery or a long flight) or appeared without an obvious cause. After that initial treatment period, the next step depends on what provoked the clot. If your DVT was triggered by a temporary risk factor, such as immobilization after surgery, you can typically stop treatment after 3 to 6 months. If the DVT was unprovoked or linked to an ongoing risk factor like an autoimmune condition, your doctor may recommend staying on a lower-dose blood thinner indefinitely to prevent recurrence.
Recurrence Is a Real Concern
DVT has a stubborn tendency to come back, especially when the original episode had no clear trigger. Among people with unprovoked DVT, about 20% experience a recurrence within two years of stopping anticoagulant therapy. The risk doesn’t disappear after that window either. It persists for many years, which is why indefinite low-dose treatment is now recommended for this group.
For people whose DVT was provoked by a temporary situation, the recurrence risk is substantially lower, and long-term blood thinners generally aren’t necessary. Understanding the cause of your clot is one of the most important factors in predicting your long-term risk.
Post-Thrombotic Syndrome
Even with proper treatment, 20% to 50% of people who have a DVT develop a chronic condition called post-thrombotic syndrome (PTS). This happens because the clot damages the valves inside the vein, leading to long-term problems with blood flow in the affected leg.
Symptoms range from mild to severe and can include persistent swelling, aching or heaviness in the leg, skin discoloration (often a brownish tint around the ankle), and in the most severe cases, open sores or ulcers on the lower leg. Most cases are mild to moderate, causing daily discomfort but remaining manageable with compression stockings, leg elevation, and regular movement. Severe PTS with ulceration affects a smaller subset of patients but can significantly impact quality of life.
PTS typically develops in the months following a DVT and can be a permanent condition. There’s no reliable way to prevent it entirely, though early and adequate anticoagulation, staying active, and wearing compression garments may reduce the severity.
Signs a DVT May Be Present
DVT doesn’t always announce itself clearly. Classic symptoms include swelling in one leg (not both), pain or tenderness that often starts in the calf and feels like a cramp, warmth in the affected area, and reddish or bluish skin discoloration. Some people have no symptoms at all, which is part of what makes DVT dangerous.
Doctors use a clinical scoring system called the Wells criteria to estimate the likelihood of DVT based on specific risk factors: active cancer treatment, recent immobilization or surgery, localized tenderness along the deep veins, swelling of the entire leg, a calf that’s more than 3 centimeters larger than the other side, pitting edema in just one leg, and visible surface veins that aren’t varicose veins. A history of previous DVT also raises the score. If another diagnosis seems equally likely, the score drops. A score of 3 or higher indicates high probability and typically leads to an ultrasound for confirmation.
Who Faces the Highest Risk
DVT affects roughly 1 in 1,000 people each year. Certain factors push that risk much higher: recent surgery (especially hip or knee replacement), prolonged bed rest, cancer and its treatment, pregnancy, use of hormonal birth control or hormone replacement therapy, obesity, smoking, and a personal or family history of blood clots. Long periods of sitting, whether on a flight or at a desk, also contribute, though they rarely cause DVT on their own without other risk factors present.
People with inherited clotting disorders face an elevated lifetime risk and are more likely to experience unprovoked or recurrent DVT. If you’ve had a clot without an obvious trigger, your doctor may test for these conditions to guide long-term prevention decisions.